Form 4 · Filed May 21, 2026, 09:08 PM UTC
INM/InMed Pharmaceuticals Inc.
ADAR1 Capital Management, LLC — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026 | P | buy | 68,551 | $2 | $109,668 | 400,000 |
| May 19, 2026 | P | buy | 200,000 | $2 | $312,080 | 600,000 |
| May 19, 2026 | P | buy | 200,000 | $1 | $299,800 | 800,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001940272-26-000008